Supreme Court of Pakistan

Inside Islamabad’s placenta case and the debate over law, medical waste and research

From the FIA raids and alleged overseas shipments to Supreme Court bail, the case raises questions about transplantation law, the scientific value of placental tissue and the safeguards governing its collection after childbirth.

ISLAMABAD: The Supreme Court has granted post-arrest bail to four accused, including three foreign nationals, in a case involving the alleged commercial collection and export of human placentas, bringing into focus a legal and medical debate over material commonly discarded after childbirth but also used in scientific research.

A two-member bench comprising Justice Shahzad Ahmad Khan and Justice Aqeel Ahmed Abbasi approved the bail applications against surety bonds of Rs1 million and two local guarantors for each accused.

The question of whether the recovered material, described as waste, attracted the offences invoked by investigators formed part of the further-inquiry issue before the court. The grant of bail does not dispose of the prosecution or amount to a final ruling permitting the commercial trade in placental material.

The case has drawn attention beyond the allegations against the accused. It raises questions about how hospitals handle placentas, who can authorise their collection, whether mothers consent to their subsequent use and how existing legislation applies to their processing and export.

The Raids and Alleged Export Operation

The investigation centres on operations carried out by the Federal Investigation Agency and the Human Organs Transplant Authority at premises in Islamabad’s F-7/1 and E-11 sectors.

According to the FIA, investigators recovered fresh and dried human placental material from the premises and uncovered an alleged arrangement for its collection, processing, preservation and shipment abroad.

A separate consignment weighing 580 kilograms was intercepted at Islamabad airport. The agency alleged that the material was being declared as sheep placenta for export to Vietnam. The prosecution has put the overall recovery in the case at 1,241 kilograms.

Investigators also alleged that placentas were being collected from hospitals and clinics in Islamabad, Punjab and Khyber Pakhtunkhwa before being brought into the supply chain.

The case was registered under Sections 9 and 11 of the Transplantation of Human Organs and Tissues Act, 2010, along with Sections 420, 109 and 34 of the Pakistan Penal Code. Earlier court coverage documented the prosecution’s reliance on these provisions and the defence’s challenge to the classification of the recovered material.

The origin, handling and intended use of the material, as well as the role attributed to each accused, remain matters for determination through the evidence.

The Dispute Over the Law

A central question is whether collecting and commercially dealing in placentas after childbirth constitutes an offence under legislation regulating human organs and tissues.

Deputy Attorney General Raja Shafqat Abbasi argued that human placenta falls within the definition covered by the transplantation law.

Advocate Mian Dawood, commenting on the case, questioned the basis on which the FIA had invoked the legislation. He argued that material discarded after childbirth should not automatically be treated in the same manner as organs removed for transplantation.

Drawing a comparison with hair collected after a haircut, he questioned whether the commercial use of discarded biological material was sufficient, by itself, to justify prosecution under organ-related offences.

The statutory wording, however, is broader than a list of named organs. Section 2(e) defines a human organ as “any part of a human body, organ or tissue”. The absence of a specific reference to placenta therefore does not, on its own, settle whether it is covered.

Section 9 concerns authorisation for removal for purposes other than therapeutic use. Section 11 addresses specified commercial dealings and provides for imprisonment of up to ten years and a fine of up to Rs1 million. These are maximum penalties, rather than an automatic sentence in every case.

The legal dispute consequently extends beyond terminology. It concerns the application of those provisions to placentas delivered during childbirth and subsequently collected, stored or traded, and whether the prosecution can establish the ingredients of the offences charged.

Dawood’s objection also raises a procedural question about the FIA’s authority to pursue the case. That issue requires examination of the applicable legal powers and prosecution record, separately from the medical classification of the material.

Why a Placenta Can Be an Organ and Hospital Waste

Medically, the placenta is a temporary organ that develops during pregnancy. It supplies oxygen and nutrients to the developing fetus, helps remove waste and performs functions essential to pregnancy. The US National Institutes of Health expressly describes it as an organ.

Its delivery after childbirth and subsequent disposal do not change that biological description. At the same time, a medical definition alone cannot establish that a particular accused has committed an offence.

This distinction is important to the debate. “Organ” describes the structure and its biological function, while “waste” describes how material is designated and handled once it is no longer required for clinical purposes.

Pakistan already has Hospital Waste Management Rules, and the Pakistan Environmental Protection Agency has undertaken inspections to enforce them in Islamabad hospitals. Disposal as medical waste therefore does not place biological material outside regulatory oversight.

For healthcare facilities, the investigation raises questions about collection records, authorisation for removal and the destination of material leaving maternity units. The allegations do not establish wrongdoing by every hospital or clinic from which investigators believe material originated.

The Scientific Value Behind the Controversy

Placental tissue and umbilical cord blood also have scientific significance, although their uses must be distinguished carefully.

Umbilical cord blood contains blood-forming stem cells used in transplantation for selected blood disorders, immune deficiencies and other serious conditions. This is an established medical application, rather than merely a proposed future use.

Broader claims about regenerative treatments require separate evidence. The potential value of birth-related tissue does not mean every product derived from it is safe, effective or approved for clinical use.

The US Food and Drug Administration has warned about unapproved products made from human cells and tissues, including placental-derived products, whose quality, safety and effectiveness have not been established through the required regulatory process.

Scientific interest in these materials also does not establish the purpose of the consignment intercepted in Islamabad. Whether the seized material was destined for research, manufacturing or another use must be demonstrated through the investigation.

Similarly, photographs and videos of stored biological material cannot establish its intended use. Speculation circulating on social media should not be confused with forensic evidence or findings of the court.

The Question of a Mother’s Consent

The debate also concerns the rights of women whose placentas may enter a collection system after delivery.

Former Islamabad Healthcare Regulatory Authority chief executive Dr Quaid Saeed, in a published commentary on the controversy, highlighted questions about ownership, informed consent and the conditions under which placental material could be collected for research or commercial purposes. He called for clearer safeguards addressing those issues.

A credible system for using such material would need to explain what is being collected, why it is required, where it will go and whether its use involves commercial activity. Documented transfers, appropriate screening, controlled processing and regulatory oversight would also be essential safeguards.

The material’s potential scientific value cannot substitute for permission to collect it. Equally, describing it as waste does not answer who may take possession of it or what conditions should govern its subsequent use.

What Remains Unresolved

The Supreme Court’s bail decision leaves the substantive allegations to be examined through the judicial process. The prosecution must establish both the conduct attributed to the accused and its connection to the offences invoked.

For Islamabad’s healthcare authorities, the wider issue is how biological material moves from hospitals and clinics into outside hands, and whether institutions maintain records capable of tracing that movement.

The case has brought criminal law, hospital practices and medical research into the same debate. Its eventual outcome will depend on the evidence and the court’s interpretation of the law, while the questions surrounding consent, traceability and responsible use of placental tissue extend beyond the fate of the four accused.

Sabeen Shahbaz

Sabeen Shahbaz is a media graduate of the International Islamic University Islamabad (IIUI) and an experienced broadcast journalist. She has worked with GTV, Neo News, BOL News, and currently serves as a reporter at GNN. Her reporting focuses on judicial proceedings, constitutional affairs, health, and political developments, covering cases from the lower judiciary to the Supreme Court of Pakistan. She specializes in legal reporting, court affairs, and constitutional developments, delivering in-depth coverage of Pakistan's judicial and legal landscape. She can be reached at sabeen@islamabadtribune.com

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button